Activinsights

. .

Alcyomics

Alcyomics a proven, experienced CRO and service-provider, Alcyomics has developed unique non-animal non-artificial human based in vitro assays that transform drug development by enabling early and accurate identification of safe and efficacious compounds. Our sensitive and highly customisable assays significantly improve the testing process making it faster, more effective and better at predicting clinical outcomes. We help clients reduce the cost of drug development, reduce the use of animal models and improve speed to market whilst providing a better return on investment. Our platform is fully human, sensitive and a cost effective approach for both toxicity and efficacy studies.

Website:
alcyomics.com

Almac Discovery

Website:
almacgroup.com
Organisation type
Dr Aaron Cranston
Head of Translational Research 
Dr Enda Gribbon
Contractor 

ARC

Website:
www.arcgroup.io/

Arecor Therapeutics

Website:
arecor.com
Organisation type
Mr David Gerring
Chief Development Officer 
Ms Jalini Gugagayanan
BD Manager 

Axol Biosciences

Website:
axolbio.com
Organisation type
Mr Ashley Barnes
Chief Scientific Officer 
Mr Liam Taylor
CEO